|
|
|
|
 |
| May 26,
2011 | ISSUE NUMBER 201 VOL 8 |
R&D
Botanical Drugs—No Patent, No Expiry?
What if a new drug could be trademarked instead of patented, keeping generics companies at bay for the life of the trademark? Or, better yet, forever?
...Read more
Commentary
Whither the Market Research Function?
Last week's Pharmaceutical Business Intelligence and Research Group meeting in San Antonio struck a note for change—because the alternative is a drift toward organizational irrelevance ...Read more
Advertisement
Critical Path Decisions for the 4 C's in Life  Sciences Streamline production, increase cash flow, and minimize risk in your Order to Cash, Contracts, Chargebacks and Compliance processes. Owens Minor Healthcare Logistics and CDC Software address the pains, the capabilities needed and results possible in these 4 "C" processes. Looking to upgrade your business solution? Get tips for making your buy, subscribe or outsourcing decision  Click here.
|
Biopharmaceuticals
Florida Boost for Biotech Industry
The Sunshine State sees a 21 percent jump in the number of biotech companies since 2008 and a surge in investment, according to the University of Florida
...Read more
Leadership
Pharma's Most Influential Leaders
Ahead of Pharm Exec's 30th Anniversary issue, which will champion 30 leaders who have had a profound effect on the industry, we're asking for who you think has had the most influence on pharma in the last three decades ...Read more
|
|
|
 // GCI Health (New York), a specialty healthcare public relations agency, announced the appointment of Becky Lauer as Senior Vice President, Director of Media. // Sanofi Pasteur (Swiftwater, Pa.), the vaccines division of Sanofi-Aventis, appointed Damian A. Braga as global head of Commercial Operations. //
Exosome Diagnostics (New York), a developer of biofluid-based molecular diagnostic tests for use in personalized medicine, announced the appointments of Bob Carter, MD; Carlos Cordon-Cardo, MD, PhD; Keith Flaherty, MD; and John Quackenbush, PhD, to its Scientific Advisory Board. //
Astellas Pharma US (Deerfield, Ill.) hired Mark Reisenauer as Vice President of Sales and Marketing, Oncology. //
Otonomy (San Diego), a clinical stage biopharmaceutical company, announced the appointment of Gerald Wroblewski as Chief Operations Officer. // |
|
|
|
|
|
 |
|
|
| |
|
 |
|
 |
| Is the pharma industry doing enough to reduce its carbon footprint? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
